Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

BACKGROUND: Hyperlipidemia is a common disease in China. Although 88.9 % of the Chinese population taking lipid-lowering medications has already used a statin, only 61.5 % of the population has reached the goal of low-density lipoprotein cholesterol. Thus, many patients in China seek help from Tradi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Liang, Zhong, Linda L. D., Cao, Yan, Chen, Wei, Cheng, Ying, Lin, Xiu-Fang, Bian, Zhao-Xiang, Lu, Ai-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912805/
https://www.ncbi.nlm.nih.gov/pubmed/27316679
http://dx.doi.org/10.1186/s13063-016-1419-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912805/
https://www.ncbi.nlm.nih.gov/pubmed/27316679
http://dx.doi.org/10.1186/s13063-016-1419-9

Ejemplares similares